back to Investors & News

Axcella to Present at the Wedbush PacGrow Healthcare Conference

August 7, 2019 at 5:54 PM EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 7, 2019-- Axcella Health (Nasdaq: AXLA),a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and support health, today announced that Bill Hinshaw, President and CEO, will present a corporate update at the Wedbush PacGrow Healthcare Conference, which is taking place at the Parker New York in New York City on August 14, 2019 at 1:55pm ET.

A live webcast of the presentation will be available on the Investors & News section of Axcella’s website at A replay of the webcast will be archived on Axcella’s website for 90 days following the presentation.

About Axcella Health

Axcella is designing and developing AXA Candidates, compositions of endogenous metabolic modulators, or EMMs, engineered in distinct ratios, designed to target and maximize the fundamental role that EMMs play in regulating multiple metabolic functions. Axcella’s AXA Candidates are generated from its proprietary, human-focused AXA Development Platform. Axcella believes its expertise and capabilities in EMMs position it to become a preeminent biotechnology company reprogramming metabolism to address a diverse set of complex diseases and support health. Axcella’s AXA Development Platform has already produced a pipeline of product candidates in programs targeting liver, muscle and blood. Axcella was founded by Flagship Pioneering.

Source: Axcella Health

Alison Williams

Lauren Stival